🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

4 big analyst cuts: Tesla stock no longer a Buy at Goldman Sachs

Published 26/06/2023, 11:36
© Reuters
GOOGL
-
AMZN
-
VTRS
-
TSLA
-
META
-
CE
-
GOOG
-

Here is your Pro Recap of the biggest analyst cuts you may have missed since Friday: downgrades at Tesla, Alphabet, Celanese , and Viatris.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Tesla downgraded at Goldman Sachs

Goldman Sachs downgraded Tesla (NASDAQ:TSLA) to Neutral from Buy with a price target of $248.00 (from $185.00) following a massive rally (up 108% YTD) in the EV maker's stock. Shares fell nearly 2% premarket today.

According to the firm, its view that Tesla is well positioned for long-term growth, given its leading position in the EV and clean energy markets, is now better reflected in the stock. While the rating change was mostly driven by valuation, the bank also noted a difficult pricing environment for new vehicles, which it believes will hurt Tesla’s non-GAAP gross margin in 2023.

This represents the fourth downgrade this month for Tesla.

InvestingPro | Prevent Losses

UBS downgraded Alphabet, sees better risk-reward in Meta and Amazon

UBS downgraded Alphabet (NASDAQ:GOOGL) to Neutral from Buy with a price target of $132.00 (from $123.00), as reported in real time on InvestingPro.

The firm’s decision to move to the sidelines is based on several factors. These include limited upside potential to the current high-single-digit Sites growth estimates, medium-term revenue risk, the possibility of operating income margin expansion being offset by GenAI investments, and the perception of better risk-reward opportunities in other stocks, specifically Meta Platforms (NASDAQ: META) and Amazon (NASDAQ: NASDAQ:AMZN).

2 more downgrades

Celanese (NYSE:CE) shares fell more than 2% premarket today after BMO Capital downgraded the company to Market Perform from Outperform and cut its price target to $119.00 from $133.00 as end market weakness is likely to persist.

Viatris (NASDAQ:VTRS) shares fell nearly 3% on Friday after Barclays downgraded the company to Underweight from Equalweight with a price target of $11.00.

Get ready to supercharge your investment strategy with our exclusive discounts.

Don't miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won't last forever!

summer sale

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.